Filing Details

Accession Number:
0001209191-15-008154
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-02-02 13:17:36
Reporting Period:
2015-01-30
Filing Date:
2015-02-02
Accepted Time:
2015-02-02 13:17:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1587221 Zosano Pharma Corp ZSAN Pharmaceutical Preparations (2834) 454488360
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1289236 Biomed Realty Trust Inc 17190 Bernardo Center Drive
San Diego CA 92128
No No Yes No
1301932 P L Realty Biomed 17190 Bernardo Center Drive
San Diego CA 92128
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-01-30 64,661 $9.35 518,904 No 4 C Indirect By BMV Direct SO LP
Common Stock Acquisiton 2015-01-30 26,543 $11.00 545,447 No 4 P Indirect By BMV Direct SO LP
Common Stock Acquisiton 2015-01-30 317,409 $9.35 1,896,982 No 4 C Indirect By BMV Direct SOTRS LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect By BMV Direct SO LP
No 4 P Indirect By BMV Direct SO LP
No 4 C Indirect By BMV Direct SOTRS LP
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock 8% Convertible Note Issued 9/9/13 Disposition 2015-01-30 337,150 $0.00 337,150 $0.00
Common Stock 8% Convertible Note Issued 9/9/13 Disposition 2015-01-30 1,101,393 $0.00 1,101,393 $0.00
Common Stock 8% Convertible Note Issued 2/26/14 Disposition 2015-01-30 267,446 $0.00 267,446 $0.00
Common Stock 8% Convertible Note Issued 2/26/14 Disposition 2015-01-30 1,148,956 $0.00 1,148,956 $0.00
Common Stock 8% Convertible Note Issued 12/2/14 Disposition 2015-01-30 717,437 $0.00 717,437 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2015-03-31 No 4 C Indirect
0 2015-03-31 No 4 C Indirect
0 2015-03-31 No 4 C Indirect
0 2015-03-31 No 4 C Indirect
0 2015-03-31 No 4 C Indirect
Footnotes
  1. The outstanding principal and accrued interest on these Convertible Notes were automatically converted into shares of the Issuer's Common Stock upon the closing of the Issuer's initial public offering at 85% of the Issuer's initial public offering price per share.
  2. BioMed Realty, L.P. (the "Partnership") is the sole general partner of BMV Direct SO LP. The sole general partner of the Partnership is BioMed Realty Trust, Inc. (the "REIT"). The REIT has sole voting and dispositive power with respect to the shares directly held by BMV Direct SO LP.
  3. BioMed Realty Holdings, Inc. ("Holdings") is the sole general partner of BMV Direct SOTRS LP. The sole shareholder of Holdings is the Partnership. The sole general partner of the Partnership is the REIT. The REIT has sole voting and dispositive power with respect to the shares directly held by BMV Direct SOTRS LP.